4//SEC Filing
Alpern Robert J 4
Accession 0001448074-26-000003
CIK 0001551152other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:00 PM ET
Size
5.9 KB
Accession
0001448074-26-000003
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
Alpern Robert J
Director
Transactions
- Award
Stock Equivalent Units
2025-12-31$228.49/sh+34$7,769→ 10,257 totalExercise: $228.49→ Common Stock (34 underlying)
Footnotes (2)
- [F1]Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.
- [F2]Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
Documents
Issuer
AbbVie Inc.
CIK 0001551152
Entity typeother
Related Parties
1- filerCIK 0001448074
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:00 PM ET
- Size
- 5.9 KB